The film unites Risk-based Monitoring (RBM) experts from a sponsor side, contract research organization, strategic advisers and technology providers. The experts provide outlook for Risk-based Monitoring for 2016:
Dr. María Proupín-Pérez, PMP – Project Leader (PPH plus)
Dr. Peter Schiemann – Managing Partner (Widler & Schiemann Ltd.)
Moe Alsumidaie – Chief Data Scientist (Annex Clinical)
Dr. Johann Proeve – Freelance Consultant (Clinical Data Management)
Dr. Artem Andrianov – CEO (Cyntegrity)
Asked Questions:
– At what stage does RBM stay now?
– How will RBM develop in 2016?
– What do you wish in 2016?
Interested in learning more about Cyntegrity and our services?
Leave A Comment
You must be logged in to post a comment.